Jiangxi Hungpai New Material (605366)

Search documents
6月23日晚间重要公告一览
Xi Niu Cai Jing· 2025-06-23 10:22
Group 1 - Beixin Road and Bridge's application for issuing shares to specific targets has been approved by the Shenzhen Stock Exchange, pending approval from the China Securities Regulatory Commission [1] - Wangbian Electric's shareholders plan to reduce their holdings by a total of up to 2.99% of the company's shares, with specific reductions detailed for each shareholder [1] - Guotou Zhonglu is planning a major asset restructuring, leading to a suspension of its stock trading for up to 10 trading days [2] Group 2 - Baiotai has signed a licensing agreement with SteinCares for the commercialization of BAT2406 in Brazil and Latin America, with total payments potentially reaching up to $10 million [3] - Dongfang Bio has obtained two medical device registration certificates for its products, which are valid until June 1, 2030 [4] - Pulaike's subsidiary has received a new veterinary drug registration certificate [5] Group 3 - Wanyi Technology has signed an agreement to establish a joint laboratory with the Energy Research Institute, with a total research and development budget of 6 million yuan [6] - Yingboer plans to use up to 300 million yuan of idle funds for financial management [7] - Blue Biological has received two new veterinary drug registration certificates [8] Group 4 - Jinkai New Energy intends to inject up to 1.247 billion yuan into its wholly-owned subsidiary to enhance its operational capabilities [9] - China Pacific Insurance's assistant general manager's qualification has been approved [10] - Zhaoyan New Drug is reducing its registered capital and notifying creditors [11] Group 5 - Weili Medical plans to invest 37.5 million yuan in establishing a medical industry investment fund [12] - Hongbai New Materials has signed a deposit agreement for idle raised funds [13] - Tongyou Technology is applying for a credit limit of 10 million yuan from a bank [14] Group 6 - Warner Pharmaceutical's subsidiary has received approval for its magnesium sulfate raw material drug [15] - Fuda Co. plans to establish a wholly-owned subsidiary with a capital contribution of 475 million yuan [16] - Yabao Pharmaceutical has obtained a loan commitment letter for stock repurchase of up to 90 million yuan [17] Group 7 - Zhongyin Securities' chairman has resigned due to work adjustments [18] - Aili Home has terminated its share reduction plan ahead of schedule [19] - Samsung New Materials has appointed a new financial officer [20] Group 8 - Guobang Pharmaceutical's subsidiary has received EU GMP certification for its product [21] - Yipin Hong has received a drug registration certificate for its injection solution [22] - Wenzhou Hongfeng's subsidiary has obtained a utility model patent certificate [23] Group 9 - Cangge Mining plans to sign a financial service agreement with Zijin Mining Group [24] - Naipu Mining's application for convertible bonds has been accepted by the Shenzhen Stock Exchange [25] - Shenyang Machine Tool has completed its major asset restructuring [26] Group 10 - Xinlaifu plans to distribute a cash dividend of 5 yuan per 10 shares [27] - Jiashitang plans to distribute a cash dividend of 1.7 yuan per 10 shares [28] - Manbuer plans to distribute a cash dividend of 2.5 yuan per 10 shares [29] Group 11 - Guo Wang Yingda plans to distribute a cash dividend of 0.51 yuan per 10 shares [30] - Changsha Bank's shareholder plans to reduce holdings by up to 0.92% [31] - Hu Nong Commercial Bank plans to distribute a cash dividend of 1.93 yuan per 10 shares [32] Group 12 - Huaxiang Co. plans to distribute a cash dividend of 1.17 yuan per 10 shares [33]
宏柏新材(605366) - 江西宏柏新材料股份有限公司关于签订募集资金协定存款协议的公告
2025-06-23 09:00
| 证券代码:605366 | 证券简称:宏柏新材 公告编号:2025-061 | | --- | --- | | 债券代码:111019 | 债券简称:宏柏转债 | 江西宏柏新材料股份有限公司 关于签订募集资金协定存款协议的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 一、募集资金的基本情况 经中国证券监督管理委员会《关于同意江西宏柏新材料股份有限公司向不 特定对象发行可转换公司债券注册的批复》(证监许可〔2024〕108 号)批复, 公 司 向 不 特 定 对 象 发 行 可 转 换 公 司 债 券 , 募 集 资 金 总 额 为 人 民 币 960,000,000.00元,扣除本次承销保荐费11,500,000.00元,募集资金净额为人 民币948,500,000.00元。中汇会计师事务所(特殊普通合伙)对本次发行的可 转换公司债券资金到位情况进行了验资,并于2024年4月23日出具了中汇会验 [2024]5260《验资报告》。公司已对可转换公司债券募集资金进行专户管理, 并与开户银行、保荐机构签订了《募集资金专 ...
宏柏新材(605366) - 江西宏柏新材料股份有限公司关于使用部分闲置募集资金进行现金管理到期赎回并继续进行现金管理的公告
2025-06-23 09:00
证券代码:605366 证券简称:宏柏新材 公告编号:2025-060 债券代码:111019 债券简称:宏柏转债 江西宏柏新材料股份有限公司 关于使用部分闲置募集资金进行现金管理到期赎回 并继续进行现金管理的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: | 序号 | 委托理财产品名称 | | | | | 委托理财期限 | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1 | 银行定期存款 | 2025 | 年 | 6 | 月 20 | 日-2025 | 年 | 12 月 | 20 | 日 | 履行的审议程序:江西宏柏新材料股份有限公司(以下简称 "公司")于 2025 年 4 月 28 日召开第三届董事会第十九 次会议和第三届监事会第十三次会议,审议通过了《关于 拟使用部分闲置可转换公司债券募集资金进行现金管理的 议案》,同意公司使用不超过人民币 70,000.00 万元(含 本数)闲置可转换 ...
宏柏新材(605366) - 江西宏柏新材料股份有限公司关于2022年员工持股计划第三个锁定期届满的提示性公告
2025-06-23 09:00
| 证券代码:605366 | 证券简称:宏柏新材 | 公告编号:2025-059 | | --- | --- | --- | | 债券代码:111019 | 债券简称:宏柏转债 | | 根据中国证监会《关于上市公司实施员工持股计划试点的指导意见》及《上 市公司自律监管指引第1号——规范运作》规定,公司2022年员工持股计划(以 下简称"本次员工持股计划")的锁定期将于2025年6月23日届满,现将本次员工 持股计划第三批股票锁定期届满相关情况公告如下: 一、员工持股计划持股情况和锁定期 2022 年 6 月 24 日,公司收到中国证券登记结算有限责任公司出具的《过户 登记确认书》,公司回购专用证券账户中所持有的 330.00 万股公司股票已于 2022 年 6 月 23 日以非交易过户的方式过户至公司 2022 年员工持股计划证券账户,过 户价格为 7.03 元/股。截至本公告披露日,公司员工持股计划账户持有公司股份 330.00 万股,占截止本公告披露日公司总股本的比例为 0.98%。 非交易过户完成后,公司实施了 2021 年度权益分派方案和 2022 年度权益分 派方案,因此,公司 2022 年员工持 ...
宏柏新材: 江西宏柏新材料股份有限公司期货和衍生品交易管理制度
Zheng Quan Zhi Xing· 2025-06-19 11:00
Core Points - The document outlines the management system for futures and derivatives trading at Jiangxi Hongbai New Materials Co., Ltd, aiming to standardize trading behavior, prevent investment risks, and protect the interests of the company and its shareholders [1][2] - The company must adhere to principles of legality, prudence, safety, and effectiveness in its trading activities, ensuring a robust internal control system and risk management [1][2] - The company is prohibited from using raised funds for futures and derivatives trading, emphasizing the importance of focusing on its main business [2] Section Summaries General Principles - Futures trading refers to transactions involving futures contracts or standardized options, while derivatives trading includes swaps, forwards, and non-standardized options [1] - The company must analyze the feasibility and necessity of investments, establish strict decision-making procedures, and define specific requirements for authorization and information disclosure [1][2] Approval Authority - A feasibility analysis report must be prepared and submitted to the board of directors for review before engaging in futures and derivatives trading [4] - Certain trading scenarios require shareholder approval if they exceed specified thresholds related to net profit and net assets [4] Professional Management - The company will establish a leadership group responsible for organizing and overseeing futures and derivatives trading, ensuring compliance with approved plans [9] - Different departments are designated for managing trading operations, market analysis, and financial management, ensuring a structured approach to trading activities [6][12] Risk Control - Strict separation of duties is mandated to prevent conflicts of interest among trading, finance, and audit personnel [14] - The company must implement stop-loss limits and regularly assess market risks, reporting findings to the leadership group and board of directors [8] Information Disclosure - The company must disclose significant losses or gains related to futures and derivatives trading that meet specified thresholds [19] - Information regarding the purpose, types, and expected financial commitments of proposed trading activities must be disclosed to ensure transparency [20] Confidentiality - All personnel involved in trading must adhere to confidentiality protocols, preventing unauthorized disclosure of sensitive trading information [22][10] Miscellaneous - The management system will be revised as necessary to comply with relevant laws and regulations, and it will take effect upon approval by the board of directors [24][25]
宏柏新材: 江西宏柏新材料股份有限公司关于召开2025年第二次临时股东大会的通知
Zheng Quan Zhi Xing· 2025-06-19 10:50
证券代码:605366 证券简称:宏柏新材 公告编号:2025-058 债券代码:111019 债券简称:宏柏转债 江西宏柏新材料股份有限公司 重要内容提示: (二)股东大会召集人:董事会 召开的日期时间:2025 年 7 月 8 日 14 点 30 分 召开地点:江西省乐平市塔山工业园区宏柏新材应用中心办公室 (五)网络投票的系统、起止日期和投票时间。 网络投票系统:上海证券交易所股东会网络投票系统 网络投票起止时间:自2025 年 7 月 8 日 至2025 年 7 月 8 日 采用上海证券交易所网络投票系统,通过交易系统投票平台的投票时间为股 东大会召开当日的交易时间段,即 9:15-9:25,9:30-11:30,13:00-15:00;通过 互联网投票平台的投票时间为股东大会召开当日的 9:15-15:00。 关于召开2025年第二次临时股东大会的通知 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 (六)融资融券、转融通、约定购回业务账户和沪股通投资者的投票程序 涉及融资融券、转融通业务、约定购回业务相关账户以及沪 ...
宏柏新材: 江西宏柏新材料股份有限公司第三届董事会第二十次会议决议公告
Zheng Quan Zhi Xing· 2025-06-19 10:49
Group 1 - The board of directors of Jiangxi Hongbo New Materials Co., Ltd. held its 20th meeting of the third session on June 19, 2025, with all 9 directors present, confirming compliance with relevant laws and regulations [1][2]. - The board approved the proposal to revise the "Derivatives Trading Management System" [1][2]. - The board also approved the proposal to engage in commodity futures hedging and trading, with a maximum margin investment of RMB 40 million and a maximum contract value of RMB 200 million at any single point in time, valid for 12 months from the date of shareholder meeting approval [2][3]. Group 2 - The board agreed to convene the second extraordinary general meeting of shareholders in 2025 on July 8, 2025, to discuss the aforementioned proposals requiring shareholder approval [2][3]. - All proposals received unanimous support from the board, with 9 votes in favor and no votes against or abstentions [2][3].
宏柏新材(605366) - 中信证券股份有限公司关于江西宏柏新材料股份有限公司开展商品期货套期保值、期货交易业务的核查意见
2025-06-19 10:31
中信证券股份有限公司 关于江西宏柏新材料股份有限公司 开展商品期货套期保值、期货交易业务的核查意见 中信证券股份有限公司(以下简称"中信证券"、"保荐人")作为江西宏柏新材 料股份有限公司(以下简称"宏柏新材"、"上市公司"或"公司")2023年度向不特 定对象发行可转换公司债券的保荐人,上述可转换公司债券已于2024年完成发行,目前 处于持续督导阶段。根据《证券发行上市保荐业务管理办法》《上海证券交易所股票上 市规则》《上海证券交易所上市公司自律监管指引第 1 号——规范运作》《上海证券交 易所上市公司自律监管指引第 11 号——持续督导》等有关法律法规和规范性文件的要求, 保荐人对宏柏新材开展商品期货套期保值、期货交易业务进行了审慎核查,并出具核查 意见如下: 一、开展商品期货套期保值、期货交易业务的概述 1、开展商品期货套期保值、期货交易业务的目的 工业硅是公司生产经营主要的原材料,其价格的大幅波动对公司成本产生一定影响。 为降低原材料价格波动风险,公司拟开展期货套期保值、期货交易业务,减少因原材料 价格波动造成产品成本波动,降低原材料价格波动对公司及子公司生产经营的影响,实 现公司及子公司业务稳定持续 ...
宏柏新材(605366) - 江西宏柏新材料股份有限公司期货和衍生品交易管理制度
2025-06-19 10:31
江西宏柏新材料股份有限公司 期货和衍生品交易管理制度 第一章 总则 第一条 为规范江西宏柏新材料股份有限公司(以下简称"公司"或"本公司") 及控股子公司的期货和衍生品交易行为,防范投资风险,强化风险控制,保证公 司资金、财产的安全,维护公司及股东利益,根据《中华人民共和国公司法》《中 华人民共和国证券法》《中华人民共和国期货和衍生品法》《中华人民共和国外 汇管理条例》《上市公司信息披露管理办法》《上海证券交易所股票上市规则》 《上海证券交易所上市公司自律监管指引第 5 号——交易与关联交易》等法律法 规、业务规则,以及《江西宏柏新材料股份有限公司章程》(以下简称"公司章 程")的规定,结合公司实际情况,特制定本制度。 第二条 本制度所称期货交易是指以期货合约或者标准化期权合约为交易标 的的交易活动。本制度所称衍生品交易是指期货交易以外的,以互换合约、远期 合约和非标准化期权合约及其组合为交易标的的交易活动。期货和衍生品的基础 资产既可以是证券、指数、利率、汇率、货币、商品等标的,也可以是上述标的 的组合。 第三条 公司开展期货和衍生品交易的基本原则 (一)公司的期货和衍生品交易应当遵循合法、审慎、安全、有效 ...
宏柏新材(605366) - 江西宏柏新材料股份有限公司关于开展商品期货套期保值、期货交易业务的可行性分析报告
2025-06-19 10:30
江西宏柏新材料股份有限公司 关于开展商品期货套期保值、期货交易业务的可行性分析报告 一、开展商品期货套期保值、期货交易业务的目的 江西宏柏新材料股份有限公司(以下简称"公司")开展商品期货套期保值、期 货交易业务旨在降低原料市场价格波动对公司生产经营成本的影响,充分利用期货市 场的套期保值、商品交易功能,降低原材料价格波动对公司及子公司生产经营的影响, 实现公司及子公司业务稳定与持续发展。 二、开展商品期货套期保值、期货交易业务基本情况 (1)主要涉及业务品种 公司套期保值、期货交易的期货品种仅限于与公司生产经营有直接关系的原料期 货品种,主要是:工业硅。 (2)业务规模及投入资金来源 公司开展商品期货套期保值、期货交易业务的资金为公司自有资金,不涉及募集 资金。 (1)市场风险:商品期货行情变动较大时,可能产生价格波动风险,造成商品期 货交易损失。 (2)资金风险:套期保值、期货交易等交易按照公司相关制度中规定的权限下达 操作指令,如投入金额过大,可能造成资金流动性风险,甚至可能因为来不及补充保 证金而被强行平仓带来实际损失。 公司商品期货套期保值、期货交易业务开展中占用的保证金最高额度不超过4,000 万 ...